Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Delanzomib with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
NCT01348919Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Aug 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of delanzomib in multiple myeloma (MM), sponsored by Teva Pharmaceutical Industries Ltd.. Started Aug 2011; status: completed.
02
Drugs
delanzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01348919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01348919.